← Back to Search

Other

Comprehensive unit based safety (CUSP) intervention arm for Dyslipidemia

N/A
Waitlist Available
Led By Gail L Daumit, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Psychiatric rehabilitation program and health home team staff, including providers and leadership are those employed by the psychiatric rehabilitation program or health home program.
English-speaking.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 and 12 months
Awards & highlights

Study Summary

This trial will test whether a new strategy can help improve care for cardiovascular risk factors in people with serious mental illness.

Eligible Conditions
  • Dyslipidemia
  • Diabetes
  • High Blood Pressure

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Only staff members who work for the psychiatric rehabilitation program or health home program can participate.
Select...
You are able to speak and understand English.
Select...
You have a severe mental illness and are currently receiving treatment as part of a psychiatric rehabilitation program.
Select...
You are able to speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in quality improvement culture as assessed by the modified version of the validated Survey on Patient Safety
Change in self-efficacy as assessed by an adapted version of Compeau & Higgins' task-focused self-efficacy scale
Secondary outcome measures
Change in Hypertension control
Change in acceptability as assessed by the Acceptability of Intervention Measure
Change in appropriateness as assessed by the Intervention Appropriateness Measure
+25 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Comprehensive unit based safety (CUSP) intervention armExperimental Treatment1 Intervention
CUSP is a quality improvement strategy developed by the Johns Hopkins University Armstrong Institute for Patient Safety and Quality that is used to improve care delivery.

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,783 Previous Clinical Trials
2,688,521 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,259 Previous Clinical Trials
14,820,025 Total Patients Enrolled
Gail L Daumit, MDPrincipal InvestigatorJohns Hopkins University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still space available to join this investigation?

"According to clinicaltrials.gov, the recruitment phase of this medical experiment is still in effect; having been first published on February 24th 2021 and recently updated on January 12nd 2022."

Answered by AI

To what extent is enrollment progressing for this experiment?

"Indeed, data hosted on clinicaltrials.gov confirms that the trial is still recruiting participants; it was posted in February of 2021 and most recently updated in January of 2022. It requires 1,200 volunteers to be recruited from one site."

Answered by AI
~154 spots leftby Apr 2025